Squamous Cell Carcinoma: Restaging and Response to Therapy

PET Clinics

Volumn 2, Issue 4, 2007, Pages 481-487

  Subramaniam, Rathan M ^a   Lowe, Val J ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

Head and neck; PET CT; Squamous cell carcinoma; Surveillance; Therapy response

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18;

CANCER RECURRENCE; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISTANT METASTASIS; HEAD AND NECK CARCINOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

EID: 64749092803     PISSN: 15568598     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpet.2008.05.008     Document Type: Review

References (35)

1. Goldman J., Cheren R., Zak F., et al. Histopathology of larynges and radical neck specimens in combined radiation and surgery for advanced carcinoma of the larynx and hypopharynx. Ann Otol 75 (1966) 313-321
2. Manara M. Histological changes of the human larynx irradiated with various technical therapeutic methods. Archives of Italian Otolaryngology 79 (1966) 596-635
3. Mukherji S., Mancuso A., Kotzur I., et al. Radiologic appearance of the irradiated larynx. Part I. Expected changes. Radiology 193 (1994) 141-148
4. Ward P., Calcaterra T., and Kagen A. The enigma of post-radiation edema and recurrent or residual carcinoma of the larynx. Laryngoscope 85 (1974) 522-529
5. Lowe V., Heber M., Anscher M., et al. Chest wall FDG accumulation in serial FDG-PET images in patients being treated for bronchogenic carcinoma with radiation. Clin Positron Imaging 1 (1998) 185-191
6. Andrade R.S., Heron D.E., Degirmenci B., et al. Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys 65 (2006) 1315-1322
7. Greven K.M., Williams III D.W., McGuirt Sr. W.F., et al. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck 23 (2001) 942-946
8. Porceddu S., Jarmolowski E., Hicks R., et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck 27 (2005) 175-181
9. Quon A., Fischbein N.J., McDougall I.R., et al. Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma. J Nucl Med 48 (2007) 58S
10. Ryan W., Fee W.J., Le Q., et al. Positron-emission tomography for surveillance of head and neck cancer. Laryngoscope 115 (2005) 645-650
11. Kim S.Y., Lee S.W., Nam S.Y., et al. The feasibility of 18F-FDG PET scans 1 month after completing radiotherapy of squamous cell carcinoma of the head and neck. J Nucl Med 48 (2007) 373-378
12. Brkovich V., Miller F., Karnad A., et al. The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Laryngoscope 116 (2006) 855-858
13. Kubota K., Yokoyama J., Yamaguchi K., et al. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radiochemotherapy: comparison with MRI/CT. Eur J Nucl Med Mol Imaging 31 (2004) 590-595
14. Yao M., Buatti J.M., Dornfeld K.J., et al. Can post-RT FDG PET accurately predict the pathologic status in neck dissection after radiation for locally advanced head and neck cancer? In regard to Rogers, et al. (Int J Radiat Oncol Biol Phys 2004;58:694-7). Int J Radiat Oncol Biol Phys 61 (2005) 306-307
15. Yao M., Graham M.M., Hoffman H.T., et al. The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 59 (2004) 1001-1010
16. Goerres G.W., Schmid D.T., Bandhauer F., et al. Positron emission tomography in the early follow-up of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 130 (2004) 105-109
17. Kitagawa Y., Nishizawa S., Sano K., et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intra-arterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med 44 (2003) 198-206
18. Klabbers B.M., Lammertsma A.A., and Slotman B.J. The value of positron emission tomography for monitoring response to radiotherapy in head and neck cancer. Mol Imaging Biol 5 (2003) 257-270
19. Lowe V.J., Dunphy F.R., Varvares M., et al. Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography. Head Neck 19 (1997) 666-674
20. Chong V.F., and Fan Y.F. Detection of recurrent nasopharyngeal carcinoma: MR imaging versus CT. Radiology 202 (1997) 463-470
21. Snow G., Annyas A., van Slooten E., et al. Prognostic factors of neck node metastases. Clin Otolaryngol Allied Sci 7 (1982) 185-192
22. Whitehurst J., and Droulias C. Surgical treatment of squamous cell carcinoma of the oral tongue: factors influencing survival. Arch Otolaryngol 103 (1977) 212-215
23. van den Brekel M., Stel H., Castelijns J., et al. Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 177 (1990) 379-384
24. Sumi M., Ohki M., and Nakamura T. Comparison of sonography and CT for differentiating benign from malignant cervical lymph nodes in patients with squamous cell carcinoma of the head and neck. AJR Am J Roentgenol 176 (2001) 1019-1024
25. Toh S., Yuen H., Goh Y., et al. Evaluation of recurrent nodal disease after definitive radiation therapy for nasopharyngeal carcinoma: diagnostic value of fine-needle aspiration cytology and CT scan. Head Neck 29 (2007) 370-377
26. Anzai Y., Carroll W.R., Quint D.J., et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses. Radiology 200 (1996) 135-141
27. Fischbein N.J., Aassar O.S., Caputo G.R., et al. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol 19 (1998) 1189-1196
28. Kao C.H., Chang Lai S.P., Chieng P.U., et al. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography. J Clin Oncol 16 (1998) 3550-3555
29. Lowe V.J., Boyd J.H., Dunphy F.R., et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol 18 (2000) 651-658
30. Wong W., Chevretton E., McGurk M., et al. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. Clin Otolaryngol Allied Sci 22 (1997) 209-214
31. Wong R.J., Lin D.T., Schoder H., et al. Diagnostic and prognostic value of [18F] fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 20 (2002) 4199-4208
32. Yao M., Luo P., Hoffman H., et al. Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment. Am J Clin Oncol 30 (2007) 264-270
33. Gourin C., Williams H., Seabolt W., et al. Utility of positron emission tomography-computed tomography in identification of residual nodal disease after chemoradiation for advanced head and neck cancer. Laryngoscope 116 (2006) 705-710
34. Brouwer J., Senft A., de Bree R., et al. Screening for distant metastases in patients with head and neck cancer: is there a role for (18) FDG-PET?. Oral Oncol 42 (2006) 275-280
35. Manolidis S., Donald P., Volk P., et al. The use of positron emission tomography scanning in occult and recurrent head and neck cancer. Acta Otolaryngol Suppl 534 (1998) 1-11